QSV To Manufacture Protein for Clinical Trial

QSV Biologics, Ltd. has signed a cGMP manufacturing contract with a California-based biopharmaceutical company. The recombinant therapeutic protein manufactured by QSV will be used in upcoming clinical studies. QSV will be responsible for technology transfer and cGMP manufacture of the clinical trial material at its cGMP manufacturing facility in Edmonton. Details of the agreement have not been disclosed.

Graeme Macaloney Ph.D., PEng, QSV president and chief executive officer said, “We are delighted to be working with this partner on their clinical trial drug requirements. Our proximity and ease of travel to California will greatly facilitate the coordination of this valuable project for the treatment of important disease indications.”